EZH2 and hepatocellular carcinoma: As our clinicopathological association study indicated that high EZH2 expression strongly correlated with proliferative and aggressive clinicopathological features in HCC patients, we therefore performed colony formation, transwell migration, and cell proliferation assays with the EZH2-depleted cells and scramble control cells.